The following table describes GLP-1 receptor agonists, their dosing frequency and key pharmacokinetic parameters: Cautions and Contraindications Adverse Effects Acute pancreatitis (rare) Injection site reactions Gastrointestinal disturbances (nausea, vomiting, diarrhoea dehydration and possible renal impairment) Increase in pancreatic enzymes: lipase and amylase (dulaglutide, tirzepatide and semaglutide) Cholecystitis and cholelithiasis Delayed gastric emptying (semaglutide, exenatide, dulaglutide, tirzepatide (diminishes over time)) Increased heart rate Diabetic retinopathy complications (semaglutide, particularly in insulin-treated patients with known diabetic retinopathy) Interactions GLP-1 receptor agonists do not interact via cytochrome P450 , but delayed gastric emptying may alter drug absorption
Most users of Lantus do not experience significant side effects
If additional treatment is needed, your healthcare provider will recommend the most appropriate schedule
Brain Res 104 (1), 5565
The arbitrators said there were numerous other examples of this type of medical direction in the record of this case. The directions involved calcium supplements, anti-inflammatories, sleep medication, and the consistent pushing of thyroid medicine that is often used to increase metabolism and control weight
With EVEXIAS Health Solutions and the personalized support from your EvexiPEL provider, you can restore balance, feel more like yourself again, and embrace long-term vitality